HUM and 9 peers, year by year
The 9 Health care companies closest to HUM in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| HUM Humana | FY2025 | $129.7B | +10.1% | - | 2.1% | 0.9% | 0.3% | 6.7% | 0.70 |
| ELV Elevance Health | FY2025 | $199.1B | +12.5% | - | 3.6% | 2.8% | 1.6% | 12.9% | 0.73 |
| CNC Centene Corporation | FY2025 | $194.8B | +20.0% | 7.3% | −3.9% | −3.4% | 2.2% | −33.4% | 0.88 |
| JNJ Johnson & Johnson | FY2025 | $94.2B | +6.0% | 67.9% | - | 28.5% | 20.9% | 32.9% | 0.61 |
| LLY Eli Lilly | FY2025 | $65.2B | +44.7% | - | - | 31.7% | - | 77.8% | 1.54 |
| HCA HCA Healthcare | FY2025 | $75.6B | +7.1% | - | - | 9.0% | 10.2% | n/m | n/m |
| MRK Merck & Co. | FY2025 | $65.0B | +1.3% | - | - | 28.1% | 19.0% | 34.7% | 0.94 |
| ABBV AbbVie | FY2025 | $61.2B | +8.6% | - | 24.6% | 6.9% | 29.1% | n/m | n/m |
| PFE Pfizer | FY2025 | $62.6B | −1.6% | - | - | 12.4% | 14.5% | 9.0% | 0.75 |
| CAH Cardinal Health | FY2026 | $254.2B | +14.2% | 3.8% | 1.0% | 0.7% | 1.8% | n/m | n/m |
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | $54.4B | $53.8B | $56.9B | $64.9B | $77.2B | $83.1B | $92.9B | $106.4B | $117.8B | $129.7B |
| ELV Dec | $84.9B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B |
| CNC Dec | $40.6B | $48.4B | $60.1B | $74.6B | $111.1B | $126.0B | $144.5B | $154.0B | $163.1B | $194.8B |
| JNJ Dec | $71.9B | $76.5B | $81.6B | $82.1B | - | $78.7B | $80.0B | $85.2B | $88.8B | $94.2B |
| LLY Dec | $21.2B | $20.0B | $21.5B | $22.3B | $24.5B | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| HCA Dec | $41.5B | $43.6B | $46.7B | $51.3B | $51.5B | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B |
| MRK Dec | $39.8B | $40.1B | $42.3B | $39.1B | $41.5B | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| ABBV Dec | $25.6B | $28.2B | $32.8B | $33.3B | $45.8B | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |
| PFE Dec | $52.8B | $52.5B | $40.8B | $40.9B | $41.7B | $81.3B | $101.2B | $59.6B | $63.6B | $62.6B |
| CAH Jun | $121.5B | $130.0B | $136.8B | $145.5B | $152.9B | $162.5B | $181.3B | $205.0B | $226.8B | $222.6B |
| Peer median | $41.5B | $48.4B | $46.7B | $51.3B | $48.7B | $78.7B | $80.0B | $65.0B | $70.6B | $75.6B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | +0.2% | −1.1% | +5.8% | +14.0% | +18.9% | +7.7% | +11.8% | +14.5% | +10.7% | +10.1% |
| ELV Dec | +7.2% | +6.1% | +2.3% | +13.1% | +16.9% | +13.8% | +13.0% | +9.4% | +3.3% | +12.5% |
| CNC Dec | +78.4% | +21.4% | +23.7% | +24.7% | +47.5% | +13.7% | +14.8% | +3.4% | +3.9% | +20.0% |
| JNJ Dec | - | +6.3% | +6.7% | +0.6% | - | +13.6% | +1.6% | +6.5% | +4.3% | +6.0% |
| LLY Dec | +6.3% | +7.8% | +7.6% | +3.8% | +9.9% | +15.4% | +0.8% | +19.6% | +32.0% | +44.7% |
| HCA Dec | - | +5.1% | +7.0% | +10.0% | +0.4% | +14.0% | +2.5% | +7.9% | +8.7% | +7.1% |
| MRK Dec | - | +0.8% | +5.4% | +10.7% | +6.1% | +17.3% | +21.7% | +1.4% | +6.7% | +1.3% |
| ABBV Dec | +12.2% | +10.1% | +16.1% | +1.6% | +37.7% | +22.7% | +3.3% | −6.4% | +3.7% | +8.6% |
| PFE Dec | - | −0.5% | +2.1% | +0.8% | +1.8% | +95.2% | +24.7% | −41.1% | +6.8% | −1.6% |
| CAH Jun | - | +6.9% | +5.3% | +6.4% | +5.1% | +6.2% | +11.6% | +13.0% | +10.7% | −1.9% |
| Peer median | +9.7% | +6.3% | +6.7% | +6.4% | +8.0% | +14.0% | +11.6% | +6.5% | +6.7% | +7.1% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | - | - | - | - | - | - | - | - | - | - |
| ELV Dec | - | - | - | - | - | - | - | - | - | - |
| CNC Dec | - | - | - | - | - | 11.5% | 11.7% | 11.5% | 10.5% | 7.3% |
| JNJ Dec | 69.7% | 66.7% | 66.8% | 66.4% | - | 70.3% | 69.3% | 68.8% | 69.1% | 67.9% |
| LLY Dec | - | - | - | - | - | - | - | - | - | - |
| HCA Dec | - | - | - | - | - | - | - | - | - | - |
| MRK Dec | - | - | - | - | - | - | - | - | - | - |
| ABBV Dec | - | - | - | - | - | - | - | - | - | - |
| PFE Dec | - | - | - | - | - | - | - | - | - | - |
| CAH Jun | 5.4% | 5.0% | 5.2% | 4.7% | 4.5% | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% |
| Peer median | - | - | - | - | - | 11.5% | 11.7% | 11.5% | 10.5% | 7.3% |
Operating margin, FY2016 to FY2025
Operating income / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | 3.2% | 7.9% | 5.4% | 4.9% | 6.5% | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% |
| ELV Dec | 5.7% | 4.6% | 5.9% | 5.8% | 5.2% | 5.5% | 5.3% | 5.0% | 4.4% | 3.6% |
| CNC Dec | 3.1% | 2.5% | 2.4% | 2.4% | 2.8% | 1.4% | 0.9% | 1.9% | 1.9% | −3.9% |
| JNJ Dec | - | - | - | - | - | - | - | - | - | - |
| LLY Dec | - | - | - | - | - | - | - | - | - | - |
| HCA Dec | - | - | - | - | - | - | - | - | - | - |
| MRK Dec | - | - | - | - | - | - | - | - | - | - |
| ABBV Dec | 36.4% | 33.8% | 19.5% | 39.0% | 24.8% | 31.9% | 31.2% | 23.5% | 16.2% | 24.6% |
| PFE Dec | - | - | - | - | - | - | - | - | - | - |
| CAH Jun | 2.0% | 1.6% | 0.1% | 1.4% | −2.7% | 0.3% | −0.3% | 0.4% | 0.5% | 1.0% |
| Peer median | 4.4% | 3.6% | 4.2% | 4.1% | 4.0% | 3.4% | 3.1% | 3.4% | 3.2% | 2.3% |
Net margin, FY2016 to FY2025
Net income / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | 1.1% | 4.6% | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| ELV Dec | 2.9% | 4.3% | 4.1% | 4.6% | 3.8% | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |
| CNC Dec | 1.4% | 1.7% | 1.5% | 1.8% | 1.6% | 1.1% | 0.8% | 1.8% | 2.0% | −3.4% |
| JNJ Dec | 23.0% | 1.7% | 18.8% | 18.4% | - | 26.5% | 22.4% | 41.3% | 15.8% | 28.5% |
| LLY Dec | 12.9% | −1.0% | 15.0% | 37.3% | 25.2% | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% |
| HCA Dec | 7.0% | 5.1% | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| MRK Dec | 9.8% | 6.0% | 14.7% | 25.2% | 17.0% | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% |
| ABBV Dec | 23.2% | 18.8% | 17.4% | 23.7% | 10.1% | 20.5% | 20.4% | 9.0% | 7.6% | 6.9% |
| PFE Dec | 13.7% | 40.6% | 27.3% | 39.2% | 22.0% | 27.0% | 31.0% | 3.6% | 12.6% | 12.4% |
| CAH Jun | 1.2% | 1.0% | 0.2% | 0.9% | −2.4% | 0.4% | −0.5% | 0.2% | 0.4% | 0.7% |
| Peer median | 9.8% | 4.3% | 14.7% | 18.4% | 8.7% | 19.7% | 20.4% | 3.6% | 8.2% | 9.0% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | $1.4B | $3.5B | $1.6B | $4.5B | $4.7B | $920.0M | $3.5B | $3.0B | $2.4B | $375.0M |
| ELV Dec | $2.7B | $3.4B | $2.6B | $5.0B | $9.7B | $7.3B | $7.2B | $6.8B | $4.6B | $3.2B |
| CNC Dec | $1.5B | $1.1B | $559.0M | $753.0M | $4.6B | $3.3B | $5.3B | $7.3B | −$490.0M | $4.3B |
| JNJ Dec | $15.5B | $17.8B | $18.5B | $19.9B | - | $19.8B | $17.2B | $18.2B | $19.8B | $19.7B |
| LLY Dec | - | - | - | - | - | - | - | - | - | - |
| HCA Dec | $2.9B | $2.4B | $3.2B | $3.4B | $6.4B | $5.4B | $4.1B | $4.7B | $5.6B | $7.7B |
| MRK Dec | $8.8B | $4.6B | $8.3B | $10.1B | $5.8B | $8.7B | $14.7B | $9.1B | $18.1B | $12.4B |
| ABBV Dec | $6.6B | $9.4B | $12.8B | $12.8B | $16.8B | $22.0B | $24.2B | $22.1B | $17.8B | $17.8B |
| PFE Dec | $14.4B | $14.8B | $13.8B | $10.5B | $12.2B | $29.9B | $26.0B | $4.8B | $9.8B | $9.1B |
| CAH Jun | $2.5B | $797.0M | $2.4B | $2.4B | $1.6B | $2.0B | $2.8B | $2.4B | $3.3B | $1.9B |
| Peer median | $4.7B | $4.0B | $5.7B | $7.5B | $6.4B | $8.0B | $11.0B | $7.0B | $7.7B | $8.4B |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | 2.6% | 6.6% | 2.7% | 7.0% | 6.1% | 1.1% | 3.7% | 2.8% | 2.0% | 0.3% |
| ELV Dec | 3.2% | 3.8% | 2.8% | 4.8% | 7.9% | 5.2% | 4.6% | 3.9% | 2.6% | 1.6% |
| CNC Dec | 3.8% | 2.2% | 0.9% | 1.0% | 4.2% | 2.6% | 3.6% | 4.7% | −0.3% | 2.2% |
| JNJ Dec | 21.6% | 23.3% | 22.7% | 24.3% | - | 25.1% | 21.5% | 21.4% | 22.3% | 20.9% |
| LLY Dec | - | - | - | - | - | - | - | - | - | - |
| HCA Dec | 7.0% | 5.5% | 6.8% | 6.7% | 12.4% | 9.2% | 6.9% | 7.2% | 8.0% | 10.2% |
| MRK Dec | 22.0% | 11.4% | 19.6% | 25.7% | 14.0% | 17.8% | 24.8% | 15.2% | 28.2% | 19.0% |
| ABBV Dec | 25.6% | 33.4% | 39.0% | 38.4% | 36.7% | 39.1% | 41.8% | 40.6% | 31.7% | 29.1% |
| PFE Dec | 27.2% | 28.3% | 33.9% | 25.8% | 29.2% | 36.7% | 25.7% | 8.0% | 15.5% | 14.5% |
| CAH Jun | 2.1% | 0.6% | 1.7% | 1.6% | 1.0% | 1.2% | 1.5% | 1.2% | 1.4% | 0.8% |
| Peer median | 14.3% | 8.5% | 13.2% | 15.5% | 12.4% | 13.5% | 14.2% | 7.6% | 11.7% | 12.3% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | 5.7% | 24.9% | 16.6% | 22.5% | 24.5% | 18.2% | 18.3% | 15.3% | 7.4% | 6.7% |
| ELV Dec | 9.8% | 14.5% | 13.1% | 15.2% | 13.8% | 17.1% | 16.3% | 15.2% | 14.5% | 12.9% |
| CNC Dec | 9.5% | 12.1% | 8.2% | 10.5% | 7.0% | 5.0% | 5.0% | 10.5% | 12.5% | −33.4% |
| JNJ Dec | 23.5% | 2.2% | 25.6% | 25.4% | - | 28.2% | 23.4% | 51.1% | 19.7% | 32.9% |
| LLY Dec | 19.5% | −1.8% | 32.9% | n/m | 109.8% | 62.2% | 58.6% | 48.6% | 74.2% | 77.8% |
| HCA Dec | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| MRK Dec | 9.8% | 7.0% | 23.3% | 38.0% | 27.9% | 34.2% | 31.6% | 1.0% | 37.0% | 34.7% |
| ABBV Dec | 128.4% | 104.2% | n/m | n/m | 35.3% | 74.9% | 68.6% | 46.9% | 128.7% | n/m |
| PFE Dec | 12.1% | 29.9% | 17.6% | 25.4% | 14.5% | 28.5% | 32.8% | 2.4% | 9.1% | 9.0% |
| CAH Jun | 21.8% | 18.9% | 4.2% | 21.5% | n/m | 34.1% | n/m | n/m | n/m | n/m |
| Peer median | 15.8% | 13.3% | 17.6% | 23.5% | 21.2% | 31.3% | 31.6% | 15.2% | 19.7% | 22.9% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | 0.38 | 0.50 | 0.60 | 0.47 | 0.49 | 0.78 | 0.73 | 0.72 | 0.72 | 0.70 |
| ELV Dec | 0.63 | 0.75 | 0.66 | 0.62 | 0.61 | 0.64 | 0.67 | 0.64 | 0.76 | 0.73 |
| CNC Dec | 0.81 | 0.70 | 0.63 | 1.10 | 0.65 | 0.71 | 0.76 | 0.70 | 0.71 | 0.88 |
| JNJ Dec | 0.41 | 0.60 | 0.55 | 0.47 | - | 0.48 | 0.54 | 0.45 | 0.54 | 0.61 |
| LLY Dec | 0.74 | 1.09 | 0.99 | 5.80 | 2.90 | 1.86 | 1.53 | 2.35 | 2.37 | 1.54 |
| HCA Dec | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| MRK Dec | 0.62 | 0.71 | 0.94 | 1.02 | 1.26 | 0.87 | 0.67 | 0.93 | 0.80 | 0.94 |
| ABBV Dec | 7.95 | 7.33 | n/m | n/m | 6.50 | 4.93 | 3.66 | 5.72 | n/m | n/m |
| PFE Dec | 0.62 | 0.61 | 0.64 | 0.81 | 0.07 | 0.49 | 0.37 | 0.81 | 0.72 | 0.75 |
| CAH Jun | 0.85 | 1.65 | 1.49 | 1.27 | 3.79 | 3.48 | n/m | n/m | n/m | n/m |
| Peer median | 0.68 | 0.73 | 0.66 | 1.02 | 1.26 | 0.79 | 0.67 | 0.81 | 0.74 | 0.81 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| HUM Dec | $4.07 | $16.81 | $12.16 | $20.10 | $25.31 | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 |
| ELV Dec | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| CNC Dec | $1.71 | $2.34 | $2.26 | $3.14 | $3.12 | $2.28 | $2.07 | $4.95 | $6.31 | −$13.53 |
| JNJ Dec | $5.93 | $0.47 | $5.61 | $5.63 | - | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 |
| LLY Dec | $2.58 | −$0.19 | $3.13 | $8.89 | $6.79 | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |
| HCA Dec | $7.30 | $5.95 | $10.66 | $10.07 | $10.93 | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 |
| MRK Dec | $1.41 | $0.87 | $2.32 | $3.81 | $2.78 | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 |
| ABBV Dec | $3.63 | $3.30 | $3.66 | $5.28 | $2.72 | $6.45 | $6.63 | $2.72 | $2.39 | $2.36 |
| PFE Dec | $1.17 | $3.52 | $1.87 | $2.82 | $1.63 | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |
| CAH Jun | $4.32 | $4.03 | $0.81 | $4.53 | −$12.61 | $2.08 | −$3.37 | $1.26 | $3.45 | $6.45 |
| Peer median | $3.63 | $3.30 | $3.13 | $5.28 | $2.95 | $6.12 | $6.63 | $4.95 | $6.31 | $7.28 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out HUM and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →
Work on HUM in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/HUM/export.csv") into a cell.